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Abstract: Andrographolide (AG) is one of the most potent labdane diterpenoid-type free radical 
scavengers available from plant sources. The compound is the principal bioactive component 
in Andrographis paniculata leaf extracts, and is responsible for anti-inflammatory, anticancer, 
and immunomodulatory activity. The application of AG in therapeutics, however, is severely 
constrained, due to its low aqueous solubility, short biological half-life, and poor cellular perme-
ability. Engineered nanoparticles in biodegradable polymer systems were therefore conceived 
as one solution to aid in further drug-like applications of AG. In this study, a cationic modified 
poly(lactic-co-glycolic) acid nanosystem was applied for evaluation against experimental mouse 
hepatotoxic conditions. Biopolymeric nanoparticles of hydrodynamic size of 229.7±17.17 nm 
and ζ-potential +34.4±1.87 mV facilitated marked restoration in liver functions and oxidative 
stress markers. Superior dissolution for bioactive AG, hepatic residence, and favorable cytokine 
regulation in the liver tissues are some of the factors responsible for the newer nanosystem-
assisted rapid recovery.
Keywords: andrographolide, engineered nanosystems, poly(lactic-co-glycolic) acid, cytokine 
regulation, hepatotoxicity
Introduction
Progressive liver damage is one of the most serious health hazards afflicting a growing 
population across the globe. Hepatic injury is one of the top ten recorded causes of 
death in the US.1 The liver is the site for drug detoxification and biotransformation of 
exogenous chemicals that penetrate body systems via different routes. Therapeutic 
strategies to alleviate conditions of hepatic injury and inflammation of the liver are 
however very rare. Furthermore, as only a few therapeutic choices are available, 
these lack hugely in specificity.2 Agents like antiviral drugs, steroids, and vaccines 
are particularly harmful to the liver when applied in prolonged treatment conditions, 
such as antitubercular, antiretroviral, or anticancer chemotherapy.3,4
Natural products and traditional herbal medicines are currently attracting a renewed 
focus as safer and effective alternatives in hepatorestorative therapy. Select supple-
ments of herbal origin are some of the confirmed hepatoprotectants, but their applica-
tions cannot be approved because of the inherent multichemical nature of plant drugs 
and lack of pinpoint activity-proficiency proof.5 Andrographolide (AG) is one of the 
most powerful anti-inflammatory agents available directly from plant sources. The 
compound effectively reduces production of reactive oxygen species (ROS), TNFα, 
nitrous oxide species, and prostaglandin E
2
 in vitro.6 Aqueous extract of the Androg-
raphis paniculata (family: Acanthaceae) plant was reported to have anti-inflammatory, 
anticancer, hepatoprotective, and immunomodulatory activities.7–9 The plant is well 
known as the “king of bitters”, and is applied in traditional Indian and Chinese systems of 
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medicine in order to alleviate chronic digestive disorders and 
liver-centric diseases. Early attempts with AG and synthetic 
prodrugs against arthritis and leishmaniasis were aborted, due 
to constraints in dissolution and targetability.10 The significant 
clinical potential of AG was thus marred due to poor aqueous 
solubility and short biological half-life of only 2 hours.11 Rapid 
metabolic sulfonation in the duodenum–jejunum areas and 
P-glycoprotein-efflux activities are some of the root reasons 
identified recently for poor bioactivity of similar terpenoids.12 
Some newer semisynthetic AG derivatives were very recently 
reported for solubility enhancement and for likely efficacy 
in hepatoprotection and retardation of apoptosis.13 We were 
further successful in applying different nanoparticle (NP)-
engineering techniques for favorable liver-localized biological 
AG activity.14 At least one report was recently noticed on the 
synthesis of solid-lipid NPs for pharmacokinetic enhancement 
and antihyperlipidemic activity of AG.15
Progressive oxidative stress is one ubiquitous health haz-
ard, and carbon tetrachloride (CCl
4
) liver damage in rodents 
is an established in vivo model for similar evaluations. CCl
4
 
is known to cause deoxyribonucleic acid methylation and free 
radical-mediated hepatocellular damages.16 When metabolized 
by the cytochrome P450 (CYP2E1) enzyme system, CCl
4
 
forms trichloromethyl (⋅CCl
3
) and trichloroperoxyl (⋅OOCCl
3
) 
radicals. Both species initiate a free radical-mediated lipid 
peroxidation that culminates in degeneration of membrane 
lipids and liver damage. The compound educes a marked rise 
in hepatic marker enzymes and lipid-peroxidation products 
like malonyldialdehyde (MDA) in the mouse.17 The aim of 
this study was to explore drug-like hepatoprotective activity 
against CCl
4
 acute liver damage models for new AG nanosys-
tems and AG alone extracted and purified directly from native 
A. paniculata leaves. The principles of NP engineering were 
applied in order to develop cationic modified AG in biopoly-
meric nanosystems for a size-directed bioactive dissolution and 
hepatorestorative evaluations upon peroral administration.
Materials and methods
Materials
The biopolymers poly(lactic-co-glycolic) acid (PLGA; 50:50, 
molecular weight [MW] 40,000–75,000), chitosan (Cs; medium 
MW), Pluronic® F-127 (MW 12,600), and dialysis tubing 
(MW cutoff 12,400) were all purchased from Sigma-Aldrich 
Co. (St Louis, MO, USA). Solvents and water used were of 
high-performance liquid chromatography (HPLC) grade, and 
were procured from Merck KGaA (Darmstadt, Germany). 
Biochemical analysis kits were from Merck KGaA and 
eBioscience (San Diego, CA, USA). Analysis procedures 
followed were as prescribed by the manufacturer unless 
mentioned otherwise. A. paniculata whole plant and the 
leaves were collected at the end of September 2012 from the 
medicinal plant gardens of Ramkrishna Mission, Narendra-
pur, Kolkata, India. The plant specimens were identified and 
authenticated by comparison, with reference to the herbarium 
(CNH/68/2012/Tech.II/887), preserved at the Indian Botani-
cal Gardens, Central Herbarium, Howrah, India.
Extraction, purification, and characterization
Powdered A. paniculata leaves (500 g) were extracted in 
95% v/v aqueous ethanol in a Soxhlet apparatus under 
refluxing for 10 hours. The extract was concentrated and 
subjected to two cycles of solid–liquid extraction in 100 mL 
of n-hexane:acetone (85:15) mixture to eliminate any residual 
chlorophyll. The resultant solid was dissolved in 250 mL 
ethanol under refluxing, and cooled, filtered, and mixed 
with activated charcoal for hot filtration under suction. The 
light-yellow liquid was concentrated to 25 mL under reduced 
pressure and charged over a 160-mesh activated neutral alu-
mina column (80×6 cm), and AG was finally eluted against 
80% v/v aqueous ethanol. The diterpenoid AG content was 
confirmed in an ultraviolet (UV)-visible spectrophotometer 
(UV-2550; Shimadzu, Kyoto, Japan). The colorless eluent 
was concentrated by evaporation and crystallized under cool-
ing in a refrigerator. Purified AG was finally recrystallized 
from absolute ethanol under anhydrous conditions and dried 
in a vacuum oven at 60°C for preservation.
A dilute solution of AG in chloroform was analyzed in 
a UV-visible spectrophotometer, and the maximum absor-
bance (λ
max
) values were recorded. Fourier-transform infra-
red (FTIR) experiments were carried out with an FTIR 670 
Plus (Jasco, Easton, MD, USA) and the melting point of the 
extracted product was determined with melting-point appa-
ratus (Systonic, Panchkula, Haryana, India). Percentage C, 
H, and N composition of AG was recorded in a CHNS ana-
lyzer model CHNS-932 (Leco Corporation, St Joseph, MI, 
USA). Mass spectra of purified AG extracted were obtained 
in a Q-Tof micro-mass spectrometer (Waters Corporation, 
Milford, MA, USA). Reverse-phase HPLC (RP-HPLC) 
analysis for AG was carried out following isocratic elution 
using a mobile phase of acetonitrile: 0.1% (v/v) phosphoric 
acid in water (40:60, v/v) at a flow rate of 1 mL/minute in 
a C
18
 column (25×4.6 mm, 5 μm; Supelco, Bellefonte, PA, 
USA) attached with one HPLC system (Waters Corpora-
tion). A peak area (y) versus concentration (x) graph for 
AG was recorded, and the linearity equation developed was 
applied to estimate AG concentrations throughout.18
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engineered nanosystem design
A facile emulsion solvent-evaporation technique was adopted 
for the synthesis of AG nanosystems in PLGA. Cationic 
modification was achieved by polyelectrolyte deposition of 
Cs biopolymer on AG in PLGA nanosystems. Briefly, 50 mg 
PLGA and 2.5 mg of AG in 3 mL of chloroform was emulsi-
fied in 12 mL of 1% w/v aqueous Pluronic F-127 solution 
by sonication (Sonics, Milpitas, CA, USA) for 1 minute and 
homogenization (Omni International, Kennesaw, GA, USA) 
at 20,000 rpm for 20 minutes. AG nanoparticles (AGNPs) 
formed were harvested by ultracentrifugation at 30,000 rpm for 
25 minutes at 4°C. An aqueous dispersion of AGNPs (2 mL, 
0.3% w/v) was added dropwise to the Cs solution (0.3% w/v) 
in aqueous acetic acid (1% v/v) under magnetic stirring at 10°C 
for 1 hour. Cs-modified AGNPs (CsAGNPs) were further 
harvested similarly by centrifugation, and were stored at 4°C 
until further analysis. Fluorescence-labeled PLGA NPs were 
prepared separately following the same procedure, but by 
replacing AG with fluorescein isothiocyanate. Each preparation 
was done in quadruplicate for drug-loading, ζ-analysis, and 
release studies. Final AG nanosystems were similarly received 
by ultracentrifugation at 30,000 rpm for 25 minutes at 4°C.
characterization for engineered 
nanosystems
Particle characterization was carried out by systematic evalu-
ation of particle size, polydispersity index, ζ-potential, and 
surface morphology. Particle size, polydispersity index, and 
ζ-potential were all measured in a Zetasizer Nano ZS (Malvern 
Instruments, Malvern, UK), while particle morphology was 
studied with atomic force microscopy (AFM; NanoScope 3A; 
Veeco Instruments, Inc., Plainview, NY, USA) and transmis-
sion electron microscopy (TEM; JEM 2100; JEOL, Japan). 
AFM tracing was done in tapping mode using an RTESP tip 
with 267–328 kHz resonance frequency at a scan speed of 
1.2 Hz. For TEM measurements, 10 μL of CsAGNP suspen-
sion in water were carefully placed on a 300-mesh formvar-
coated copper TEM grid (Ted Pella, Inc., Redding, CA, USA) 
and stained in 2% w/v of uranyl acetate solution for 1 minute. 
The excess solution on the grid was removed using a piece of 
fine-filter paper, and the samples were allowed to air-dry for 
10 hours prior to imaging the particles under TEM. AGNP-
entrapment efficiency was recorded in HPLC as described 
previously. The mass of AG in solution before and after final 
NP harvesting in the supernatant was estimated in HPLC for 
determination of molecular mass load.19
The X-ray diffraction (XRD) patterns of AG extracted and 
the new nanosystem CsAGNPs were obtained in an X-ray 
diffractometer (PANalytical, Almelo, the Netherlands) at an 
applied voltage of 40 kV. The scanned angle was set from 
3°2θ50°, and the scanned rate was 2 min-1. For FTIR 
functional group analysis, KBr disks impregnated with NPs 
were scanned against blank over a wave number range of 
4,000–400 cm-1. Cs content in the CsAGNP nanosystem was 
determined quantitatively following electrostatic interaction 
reactions of Cs with alizarin red dye before and after NP 
harvesting in the supernatant.19
In vitro dissolution
CsAGNPs equivalent to 2 mg AG were dispersed separately 
in 1 mL of 100 mM phosphate-buffer solution and washed 
completely into dialysis bags for equilibrating dissolution 
analysis. A buffer of pH 7.4 was used throughout.20 The 
dialysis bags were placed in individual glass vials contain-
ing 10 mL of phosphate buffer maintained at 37°C over a 
magnetic stirrer, and AG dissolution over time was recorded 
in HPLC analysis. The buffer content in the dissolution 
vials was substituted with fresh buffer medium at each time 
interval in order to maintain sink conditions. The release 
data were averaged from four different experiments in each 
case, and were further fitted in Korsmeyer–Peppas models 
for iterative release exponent analysis using SigmaPlot® 6.0 
software (Systat Software, Inc., San Jose, CA, USA).
In vivo evaluation of engineered 
nanosystems
animals and treatments
Healthy male Swiss albino mice (body weight 25±2 g) were 
used for the study. Animals were housed in plastic cages bed-
ded with rice husk, and were allowed to adapt for 5 days in 
the laboratory conditions of 25°C±2°C and 12/12 light/dark 
cycles. All animals received humane care, and the experiments 
were conducted as per the approval of the Institutional Animal 
Ethics Committee, Government of India (506/05/b/CPCSEA). 
They were given free access to a standard pellet diet (Hindustan 
Unilever Limited, Mumbai, India) and water ad libitum. The 
animals were fasted overnight, and on the day of the experiment 
only water was allowed. The experiment involved four groups 
of six animals each in the following treatment schedule:
•	 Group I: control animals gavaged with saline 10 mL/kg 
body weight for 7 days
•	 Group II: saline + CCl
4
, 10 mL/kg body weight in 0.1% 
w/v olive oil, intraperitoneally
•	 Group III: powdered AG in saline 50 mg/kg body weight 
gavaged + CCl
4
, 10 mL/kg body weight in 0.1% w/v olive 
oil, intraperitoneally
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•	 Group IV: CsAGNPs in saline equivalent to AG 50 mg/kg 
body weight gavaged + CCl
4
 10 mL/kg body weight in 
0.1% w/v olive oil, intraperitoneally.
Groups III and IV received the respective daily treatment 
of AG or CsAGNPs for the entire 7-day study period. A single 
dose of CCl
4
 was administered on day 7 (groups II, III, and 
IV) 1 hour after the final treatment to induce hepatotoxicity.21 
Group I served as the normal control while group II was the 
CCl
4
 hepatotoxic control group.
Measurement of liver enzymes in serum
Twenty-four hours after the CCl
4
 injection, the animals were 
anesthetized and the blood was collected by cardiac puncture. 
Collected blood samples were centrifuged (3,500 rpm/min, 
10 minutes at 4°C) and the serum separated and stored at -20°C 
for subsequent determination of biochemical parameters. The 
activities of aspartate aminotransferase (AST), alanine transam-
inase (ALT), and alkaline phosphatase (ALP) were determined 
using standard analysis kits (Ecoline; Merck KGaA).
Tissue samples
Animals were killed by cervical dislocation immediately 
after collection of blood, and the liver tissue in each case was 
dissected out. Liver samples were washed with ice-cold saline 
and stored in a -20°C freezer for further analysis.
histopathology
For histopathological analysis, the liver tissues from two ani-
mals in each group were fixed in 10% formalin, processed fol-
lowing routine histology procedures, and embedded in paraffin. 
Tissue sections (6–7 μm) were then stained with hematoxylin 
and eosin dye, and subjected to photomicroscopy (B1 series; 
Motic, Xiamen, People’s Republic of China) observations.22
Preparation of liver-tissue homogenate
Individual liver tissue in all other cases was crushed in a tissue 
homogenizer, and 10% w/v tissue homogenates were prepared 
with cold 50 mM sodium phosphate buffer (pH 7.0) containing 
0.1 mM ethylenediaminetetraacetic acid. Solutions were cen-
trifuged at 6,000× g at 4°C for 20 minutes, and the supernatant 
was collected for different biochemical analyses.
Determination of lipid peroxidation
The extent of lipid peroxidation was estimated spectrophoto-
metrically in the tissue homogenates following estimation of 
MDA in the thiobarbituric acid reaction,23 and was expressed 
in terms of μM/mg of liver tissue.
Determination of antioxidant-enzyme markers
Superoxide dismutase (SOD; EC1.15.1.1) in the liver was 
assayed at 480 nm based on the inhibitory effect on epineph-
rine autoxidation to adrenochrome in an alkaline medium 
(pH 10.2),24 and the catalase (CAT; EC 1.11.1.6) activity was 
measured at 240 nm from the rate of decomposition reactions 
of H
2
O
2
.25 Glutathione (GSH) peroxidase (GPx) activity was 
determined by its ability to catalyze the oxidation of GSH 
by tert-butyl hydroperoxide.26 GSH reductase (GR) was 
measured by the decrease in absorbance due to the oxidation 
of nicotinamide adenine dinucleotide phosphate (NADPH) 
to reduced nicotinamide adenine dinucleotide, accompanied 
with the reduction of GSH.27 GSH S-transferase (GST) was 
estimated by measuring the rate of GSH conjugation with 
1-chloro-2,4-dinitrobenzene as substrate.28
Determination of gsh/gssg in liver tissues
The concentration of reduced GSH in liver tissues was mea-
sured following Ellman’s method,29 whereas oxidized GSH 
was measured by the NADPH GR system at 412 nm. The 
concentration was expressed as GSH disulfide (GSSG; μM) 
in liver tissues.30 The GSH/GSSH ratio was then calculated 
by dividing the difference between the total GSH and GSSG 
concentrations.
Determination of inflammatory markers
The levels of the inflammatory cytokines (TNFα and IL-6) 
in serum were determined using commercially available 
enzyme-linked immunosorbent assay kits (eBioscience) 
according to the manufacturer’s protocol. TNFα and IL-6 
were determined from a standard curve, and the concentra-
tions are expressed as pg/mL.
statistical analysis
All results are presented as means ± standard error of the 
mean. Statistical significance was assessed using one-way 
analysis of variance with post hoc pairwise comparisons 
between groups (groups I–VI) using the Bonferroni method. 
For all analyses, P0.05 was considered to be significant, 
and P0.001 was considered highly significant. Statistical 
analysis was performed using the computer statistical pack-
age SPSS 10.0 (SPSS Inc., Chicago, IL, USA).
Results
extraction and analysis
The yield of AG diterpenoid lactone from A. paniculata 
dry leaves was 10.5 g, which was ∼2.1% on a w/w basis. 
The melting point and retention-factor value for AG were 
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recorded as 229°C±1°C and 0.83, respectively. AG was ana-
lyzed after purification for C, H, and N percentage composi-
tion. The carbon percentage in AG was recorded as 68.49% 
and that for hydrogen was 8.25%, with nil recordings for 
the elemental nitrogen. The theoretical compositions for 
carbon and hydrogen in AG were C 68.57% and H 8.57%, 
respectively. The comparative percentage-composition 
analysis indicated that AG, which was extracted and puri-
fied, was of sufficient purity, and could be used for further 
drug-like studies.
In FTIR scans, the characteristic AG lactone ring 
responded at 1,727 cm-1 and the conjugated C=C vibra-
tions were recorded at 1,674 cm-1, which matched well 
with a previous report.31 The C–O stretching responses 
from the primary and the secondary alcoholic functions 
were recorded at 1,030 cm-1 and at 1,078 cm-1. AG 
O–H stretching vibrations were recorded at 3,402 cm-1, 
indicating an intermolecular hydrogen-bonded structure, 
and the O–H in-plane bending appeared at 1,420 cm-1 
(Figure 1A). The UV λ
max
 for AG in chloroform solution 
was recorded at 228 nm (Figure S1). Characteristic AG 
electrospray ionization mass spectrometry was recorded 
with m/z: 373 (M + Na)+ and 389 (M + K)+ (Figure 1B). 
The results were typical and similar to an earlier report.32 
AG was routinely analyzed by RP-HPLC, and the λ
max
 was 
detected at 228 nm, with retention time of 4.5 minutes. 
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Figure 1 (A) FTIr scan of ag; (B) electrospray ionization mass spectra of ag; (C) X-ray diffraction spectra of ag and csagNP nanosystems; (D) FTIr scan of biopolymer 
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A standard curve was  plotted from AG concentration ver-
sus peak area, and a linear relationship was established.18 
The correlation coefficient R2 was recorded using Sigma-
Plot 6.0 software as 0.9979.
Nanosystem characterization
Average photon-correlation spectroscopy particle size of 
CsAGNPs was recorded as 229.7±17.17 nm, with a near-
Gaussian particle distribution and polydispersity index 
of 0.234±0.02 (Figure 2A). CsAGNPs exhibited cationic 
surface charge with a ζ-potential value of +34.4±1.87 mV. 
The AFM 3-D data for CsAGNP preparations (Figure 2B) 
matched with TEM observations (Figures S2 and S3) for 
mostly spherical particles with smooth surface topography 
and minimal coalescence. Entrapment efficiency is a crucial 
parameter governing the therapeutic performance of the 
delivery device. AG mass loading in CsAGNPs determined 
by RP-HPLC was 85.37%±2.9%.
XRD patterns of AG exhibited sharp peaks (Figure 1C) 
at a 2θ scattered angle (2θ=10°, 12°, 15°, and 16°), indi-
cating its crystalline nature, similar to that in an earlier 
report.33 XRD study of CsAGNPs revealed no sharp 
characteristic peak of AG, indicating that AG entrapment 
in the nanosystems likely occurred in amorphous form. 
A reaction in alizarin red was used for quantitative esti-
mation of Cs in the final nanosystems. A standard graph 
plotted at 571 nm in an acidic pH environment (pH 5) was 
applied, and the Cs mass-percentage entrapment on CsA-
GNPs was recorded from an average of four experiments 
as 74.02%±3.78%.
When scanned alone in FTIR spectroscopy (Figure 1D), 
Cs responded at 1,656 cm-1 and 1,591 cm-1 due to amide I 
and amide II vibrations, and the –O–H response appeared 
at 3,404 cm-1. However, in CsAGNP FTIR scans, a strong 
shift for amide I appeared at 1,624 cm-1, likely due to 
electrostatic interaction alongside a weak signal for the 
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designated chitosan –N–H vibrations (Figure 1E). Strong 
electrostatic interaction between biopolymeric COO- and 
Cs NH
3
+ functions assisted in Cs attachments on Pluronic 
stabilized PLGA NP surface. That was also one reason 
likely for positive ζ-value observation due to Cs embed-
ding in the case of CsAGNPs. When AG PLGA NPs alone 
were studied in photon correlation-spectroscopy, the ζ-value 
observation and particle size recorded were -29.7±1.41 mV 
and 181±12.60 nm, respectively.
In vitro dissolution
Time-dependent dissolution for CsAGNPs was studied, 
and the cumulative percentage release over time is plotted 
in Figure 2C. The release response for CsAGNP nanosys-
tems showed a biphasic character. A rapid dissolution of 
AG occurred only up to 8 hours, followed by a sustained 
effect over an observation period of 432 hours. In CsAGNP 
dissolution for AG, the initial burst was comparatively slow, 
possibly due to a Cs and PLGA matrix biopolymer interac-
tion surface. CsAGNPs showed almost a 50% release of the 
therapeutic load by 132 hours, and 83% of the initial AG load 
was traced during the study period. Similar observations for 
sustained release in Cs bedecking were recorded earlier in 
Cs-embedded NPs for Sn-38.20
The drug-release data of CsAGNPs were further fitted 
to a power-law equation to account for the overlapping 
effects of Fickian diffusion and likely viscoelastic relax-
ation in polymeric carrier systems.34 CsAGNPs produced a 
release exponent (n) value of 0.52, indicative of anomalous 
transport,35 wherein both diffusion and dissolution are quite 
indistinguishable and occur simultaneously.36
liver-function markers and histopathology
Due to hepatic injury, the liver-function markers ALT, AST, 
and ALP were elevated significantly in the CCl
4
-treated 
group when compared to the control. AG and CsAGNPs 
attenuated the CCl
4
-induced elevation of serum enzyme 
parameters (Table 1, P0.001). However, when the AG- and 
CsAGNP-treated groups were compared, the latter treat-
ment group showed significant (P0.05) improvement in 
all parameters.
Histopathological observations of the liver tissues of 
the CCl
4
-treated groups (Figure 3) indicated disruptions in 
the liver cytoarchitecture. Hepatocellular necrotic lesions, 
leukocyte infiltration, disintegrated central veins, and fatty 
changes were observed in the CCl
4
-treated group. In case of 
group I, no necrotic lesions or vascular degradation was noted 
and the cellular architecture was normal (Figure 3). Animals 
pretreated with AG showed comparative improvements in 
histology, as evident from the mild necrotic lesions. The 
CsAGNP-treated group showed ameliorated CCl
4
-induced 
hepatic damage, and the liver tissues showed significant 
regeneration, as evident from the absence of cellular necrosis 
and inflammatory infiltrates, which was comparable to that 
in the control group.
hepatic lipid peroxidation
CCl
4
 treatment significantly increased the level of hepatic 
lipid peroxidation, as judged by MDA levels of liver 
homogenate (Table 1). Both AG and CsAGNP treatment 
decreased hepatic MDA levels; however, the new nano-
system afforded an enhanced degree of protection (34.4% 
decrease compared to the CCl
4
 group) than that for the 
AG-treatment group (27.1% decrease compared to the CCl
4
 
group), which was statistically significant (P0.05).
effect of csagNPs on hepatic 
antioxidant enzymes
The activities of the antioxidant enzymes (SOD, CAT, GPx, 
GR, and GST) in the liver tissue are shown in Figure 4. The 
activity of antioxidant-enzyme activity was significantly 
(P0.001) decreased in the CCl
4
-treated group compared to the 
control group. AG- or CsAGNP-pretreated groups showed sig-
nificant increase in activities of most of the antioxidant enzymes 
Table 1 liver function markers and lipid peroxidation in treatment conditions
Groups AST (IU/L) ALT (IU/L) ALP (IU/L) Hepatic MDA level  
(nM/mg liver tissue)
control 48.33±5.44 71.50±8.36 66.00±8.39 45.67±6.56
ccl4 157.83±19.77 201.83±19.53 187.83±17.16 86.83±10.17
ag 106.67±13.41* 136.67±20.26* 140.00±16.20* 63.33±12.16*
csagNPs 84.83±7.25*, ** 105.50±10.60*, ** 108.83±14.93*, ** 57.00±8.07*, **
Notes: *P0.001, significant difference compared with CCl4-treated group; **P0.05, significant difference compared among AG- and CsAGNP-treated groups. Results 
are expressed as means ± standard deviation (n=6).
Abbreviations: asT, aspartate aminotransferase; alT, alanine transaminase; alP, alkaline phosphatase; MDa, malonyldialdehyde; ag, andrographolide; csagNPs, 
chitosan-modified AG nanoparticles.
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(P0.05) when compared to that of the CCl
4
-treated group. 
However, CsAGNPs showed marked improvement (SOD 
57.2%, CAT 53.1%, GPx 50.6%, GR 30%, and GST 50.6%) 
when compared to that of the only AG-treated group (SOD 
25.8%, CAT 28%, GPx 21%, GR 13.5%, and GST 20.5%).
effect of csagNPs on hepatic 
nonenzymatic antioxidants
Mice treated with CCl
4
 had a marked depletion (P0.001) 
in hepatic GSH levels with a concomitant increase in GSSG 
levels (P0.001) in comparison with the control group. That 
impacted the GSH/GSSG ratio in the liver tissues (Table 2). 
Administration of AG resulted in moderate restoration 
of hepatic GSH content (35%), which was statistically 
insignificant; however treatment with CsAGNPs markedly 
improved hepatic GSH content (62.4%, P0.05). Concomi-
tantly, the only AG treatment failed to reduce hepatic GSSG 
levels significantly (13%, P0.4), but CsAGNP treatment 
resulted in a significant decrease in hepatic GSSG levels 
(22.2%, P=0.02). A similar observation was reflected in the 
GSH/GSSG ratio, where CsAGNP treatment in significant 
improvement (111.9%, P0.05), whereas the only AG treat-
ment failed to elicit such response (56.3%, P0.05).
Effect on serum levels of inflammatory 
markers
CCl
4
 treatment caused a significant increase in the levels 
of both the inflammatory markers TNFα and IL-6 in serum 
samples (P0.001). Pretreatment with AG and CsAGNPs 
helped in lowering the TNFα and IL-6 levels (Table 3) when 
compared to the CCl
4
-treated control group. However, a 
superior impact in TNFα levels in the CsAGNP-treated group 
was recorded and statistically significant when compared to 
that of the only AG-treated group (P0.05).
Discussion
AG is a potent anti-inflammatory, antiapoptotic, and immu-
nomodulator compound, but is imperfect in therapeutics due 
to inadequate drug pharmacokinetics. A. paniculata extracts 
are traditionally applied for multiple ailments, but seasonal 
variation in compound yield is one of the known limiting fac-
tors in intended pharmacology efficacy.37 Structural tailoring 
attempted earlier on AG diterpenoid lactone was not very 
successful in activity enhancement or pharmacokinetics.38 It 
is also imperative to follow an appropriate isolation and stan-
dardization technique for optimum product yield. A further 
dissolution enhancement is also crucial in order to meet the 
requirements in drug-like applications of AG. Leaves col-
lected during the month of September provided a higher yield 
of nearly 2% w/w in a solvent-extraction and chromatography 
procedure. New nanosystems with AG as a payload were 
prepared exploiting the similar solubility profile of AG and 
the biopolymer PLGA. Cs bedecking on the PLGA NP sur-
face was considered for an improvement in biocompatibility 
and permeability necessary for peroral activity. Besides, the 
Cs polysaccharide has a number of –OH and –NH groups 
that provide ample opportunities for intermolecular hydro-
gen bonding with PLGA, which allows favorable particle 
engineering for the newer nanosystems. An FTIR study in 
KBr pellets has amply demonstrated structurally favorable 
biopolymer interactions (Figure 1E). Bioconjugation of Cs 
due to noncovalent interactions on the NPs provided for a 
ζ-shift and biopolymer bedecking. AG dissolution in the case 
of CsAGNPs was also consistent and traceable following an 
anomalous mass transport.
Liver is a self-regenerating tissue, but progressive and 
often irreversible degenerations are commonly caused by 
different chemicals, drugs, virus overloads, and in cases 
of alcoholic and nonalcoholic fatty liver diseases. Marked 
increases in liver diseases due to lifestyle changes and 
toxic exposures are presently one alarming concern in per-
sonal health management.39,40 Progressive oxidative stress 
and persistent inflammatory conditions are some of the 
paramount causes for critical hepatotoxicity.41 Considerable 
research for hepatoprotective therapeutics is under way, and 
liver injury by CCl
4
 intoxication serves as one of the most 
well-characterized in vivo models for investigation of these 
newer entities. The CCl
4
 chemical hepatotoxin induces free 
radical-mediated hepatocellular damages that eventually lead 
Normal CCl4
CsAGNPsAG
Figure 3 histopathological changes of liver cytoarchitecture after various treatments, 
magnification 400×, normal liver, ccl4-treated liver, ag-treated liver, csagNP-
treated liver.
Abbreviations: AG, andrographolide; CsAGNPs, chitosan-modified AG nanoparticles.
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Figure 4 levels of hepatic enzymatic antioxidant markers before and after ccl4-induced hepatotoxicity. results are expressed as means ± standard deviation (n=6).
Notes: *P0.001, significant difference compared with CCl4-treated group; **P0.05 significant difference compared among AG- and CsAGNP-treated groups.
Abbreviations: AG, andrographolide; CsAGNPs, chitosan-modified AG nanoparticles; SOD, superoxide dismutase; CAT, catalase; GPx, glutathione peroxidase; GR, 
glutathione reductase; gsT, glutathione S-transferase.
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to membrane-lipid peroxidation and necrosis. CCl
4
 toxicity 
correlates well with the conditions of oxidative stress in the 
decrease of antioxidant enzymatic activity and progressive 
loss of nonenzymatic antioxidants.42 Such enzymes as SOD, 
CAT, GR, and GPx are all downregulated in CCl
4
-induced 
hepatotoxicity. CCl
4
 is also known to decrease the detoxi-
fication system produced by GST.43 CsAGNPs afforded 
an increase in the activities of the antioxidant enzymes in 
CCl
4
-damaged liver. This effect is a contrastingly significant 
improvement over that of AG treatment alone (Figure 4). 
CCl
4
 also causes elevation of marker enzymes, such as 
ALT and AST, in serum, due to hepatocellular damage 
and release of cytoplasmic enzymes into the bloodstream.43 
Once exposed to CCl
4
 hepatocellular damage, the membrane 
permeability gets altered with the release of cytoplasmic 
enzymes into the bloodstream.
In our study, a significant increment of ALT (64%) and 
AST (64%) occurred after only CCl
4
 intoxication, indicating 
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Table 3 Serum levels of inflammatory markers
Groups Serum TNFα level  
(pg/mL)
Serum IL-6 level 
(pg/mL)
control 77.50±9.20 52.8±6.09
ccl4 247.82±20.66 109.33±11.15
ag 149.13±16.26* 71.94±8.12*
csagNPs 112.18±12.52*,** 63.84±6.13*
Notes: *P0.001, significant difference compared with CCl4-treated group; 
**P0.05, significant difference compared among AG- and CsAGNP-treated groups. 
results expressed as means ± standard deviation (n=6).
Abbreviations: AG, andrographolide; CsAGNPs, chitosan-modified AG nanoparticles.
A B
Figure 5 Fluorescein isothiocyanate-labeled nanoparticle localization in the liver 
after 4 hours of administration.
Notes: (A) Transmitted image; (B) fluorescent image.
Table 2 Nonenzymatic hepatic antioxidants in ccl4-induced hepatotoxicity
Groups Hepatic GSH  
(µM/mg liver tissue)
Hepatic GSSG  
(µM/mg liver tissue)
GSH/GSSG
control 8.618±1.20 0.755±0.09 11.66±2.86
ccl4 4.567±0.66 1.082±0.15 4.28±0.82
ag 6.17±1.21 0.943±0.12 6.69±1.81
csagNPs 7.417±1.33* 0.843±0.13* 9.07±2.72*
Notes: *P0.05, significant difference compared with CCl4-treated group. results expressed as means ± standard deviation (n=6).
Abbreviations: GSH, glutathione; GSSG, GSH disulfide; AG, andrographolide; CsAGNPs, chitosan-modified AG nanoparticles.
loss of functional integrity of the liver-cell membranes. It 
was observed further that among the AG- or CsAGNP-pre-
treatment groups, CsAGNPs favored enhanced suppression 
of CCl
4
-induced liver injury, which was evident in a decrease 
of serum marker enzymes. Similarly, suppression of elevated 
ALP activities by the nanosystems indicated improvements 
in hepatobiliary functions. Histopathological examination of 
hepatocellular damage after CCl
4
 administration indicated 
typical centrilobular necrosis, ballooning of hepatocytes, 
infiltration, and steatosis. CsAGNP nanosystems maintained 
normal histoarchitecture and demonstrated a regenerative 
effect on the hepatocytes even after oxidative stress induced 
by CCl
4
 administration (Figure 3). AG to some extent ame-
liorated degenerative changes, but some of the hepatocytes 
still demonstrated restricted ballooning necrotic changes. 
CsAGNPs were therefore demonstrably effective in exerting 
hepatoprotective efficacies.
One likely reason for a verifiable efficacy of CsAGNPs was 
considered due to liver-centric dissolution. NPs, particularly 
the cationic ones with a diameter of ∼200 nm, are prone to 
endocytosis and rapid localization in the liver tissues.44 In 
order to understand such effects, a group of 12 animals were 
fed separately with a similar Cs-engineered PLGA nano-
system carrying fluorescein isothiocyanate dye in place of 
AG. Liver-histology study under confocal microscopy was 
then performed at hourly intervals (Figure 5). The observa-
tions clearly demonstrated a rapid rise in FITC fluorescein 
isothiocyanate, which reached saturation within 4 hours of 
administration. CsAGNP hydrodynamic size observed was 
229.7±17.17 nm, and the particles were carrying a surface 
charge of +34.4±1.87 mV, which could be some of the 
basis for enhanced hepatoprotection extended by the new 
nanosystems.
In CCl
4
-induced hepatic injury, free radicals activate 
Kupffer cells, which mediate the hepatic inflammation 
process by producing TNFα and other proinflammatory 
cytokines like IL-6. Elevation of IL-6 and TNFα levels are 
always associated in liver-damage conditions.45 Proinflam-
matory cytokines are known further to induce apoptosis and 
cellular necrosis. Moreover, elevated levels of cytokines 
induce nitric oxide production, a highly reactive oxidant 
molecule, leading to an imbalance in the oxidative state. 
In our study, the serum levels of TNFα were low in the 
normal control animals, but increased considerably in 
the CCl
4
-treated animals. CsAGNP pretreatment strongly 
inhibited the elevated TNFα production after CCl
4
 injec-
tion. Reduced levels of TNFα might play a protective 
role against liver damage by inducing hepatocyte prolif-
eration and by modulation of the release of tissue-repair 
mediators.
MDA is the indicator of lipid peroxidation. MDA 
levels increased upon CCl
4
 administration, suggesting 
increased lipid-peroxidation activities due to the formation 
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of excessive ROS and failure of the antioxidant defense 
mechanism, which led to tissue damage. MDA levels were 
restored toward normal after AG and CsAGNP treatment, 
with a better restorative effect being observed in the case 
of the CsAGNP-treated group. GSH is one of the most 
abundant low-molecular-weight thiols, and protects cells 
against ROS as well as toxic compounds by its reduction 
ability. The level of GSH gives a clear indication of the 
cellular oxidation state. GSH plays a key role in eliminat-
ing the reactive toxic metabolites of CCl
4
, and depletion 
of GSH stores leads to cellular necrosis. GPx-mediated 
reduction of oxygen radicals converts GSH to its oxidized 
form – GSSG. GR, an NADPH-dependent enzyme, converts 
GSSG to GSH. GSH/GSSG is the major redox couple in 
animal cells, and in normal conditions, the cellular GSSG 
level remains in a very low concentration, around 2%–10% 
of total GSH level.46 In an oxidative environment, a consid-
erable shift toward GSSG was observed, and as a result the 
GSH/GSSG ratio decreased, indicating a state of oxidative 
stress.47 The GSH/GSSG ratio was increased due to both 
the AG and CsAGNP treatments. However, the effect of 
CsAGNP was overriding.
Conclusion
We summarize that the engineered AG nanosystem CsA-
GNPs extended a tissue-centric defense against oxidative 
stress-induced liver-damage conditions. Upregulation of 
various antioxidant enzymatic machineries and restoration 
of hepatic GSH levels are some of the reasons identified for 
superior hepatoprotection. The AG nanosystem directed a 
favorable cytokine regulation and facilitated recovery in 
CCl
4
-damaged hepatoarchitecture. Confocal microscopy 
observations recorded a rapid localization of CsAGNPs 
in the liver tissue within 4 hours of administration via the 
oral route. New engineered AG nanosystems therefore 
extend one possibility in cases of oxidative stress and 
hepatocellular inflammatory conditions. Further pharma-
cokinetic studies of similar engineered nanosystems are 
warranted to permit entry in clinical studies, and such 
study is under way.
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Supplementary materials
Figure S1 Ultraviolet maximum absorbance for andrographolide extracted in 
5 μg/ml chloroform solution.
Note: The arrows (numbered 1, 2, and 3), indicate specific peak positions for 
andrographolide in UV-visible scanning.
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Figure S2 engineered andrographolide nanosystems in water: transmission electron microscopy.
Figure S3 Irregular andrographolide crystals in water: transmission electron 
microscopy.
